Page 1 | Search Results | Blood | American Society of Hematology

1-20 of 61

Sort by

Sort Order Select

Journal Articles

Pilot Study of Tocilizumab in Patients with HIV and Symptomatic Kaposi Sarcoma Herpesvirus (KSHV)-Associated Multicentric Castleman Disease

Ramya Ramaswami, MBBS, MPH, Kathryn Lurain, MD MPH, Anaida Widell, Mark N. Polizzotto, Priscila H. Goncalves, MD, Matthew Lindsley, Seth M. Steinberg, PhD, Denise Whitby, Thomas S. Uldrick, MD MS, Robert Yarchoan, MD

Blood (2018) 132 (Supplement 1): 2894.

https://doi.org/10.1182/blood-2018-99-113119

Published: 2018

Journal Articles

Clinicogenetic risk modeling in ATL

Noriaki Yoshida, David M. Weinstock

Blood (2018) 131 (2): 159–160.

https://doi.org/10.1182/blood-2017-11-815472

Published: 2018

Journal Articles

Adult T-Cell Leukemia/Lymphoma: Clinical Characteristics and Outcome of Aggressive Subtypes Treated at a Tertiary Cancer Center

Yung Bruno de Melo Gonzaga, MD, Lavinia Bergier, MD MSc, Fabio Leal, MD PhD, Ricardo Bigni, MDMPH, Jane Dobbin, MD

Blood (2017) 130 (Supplement 1): 5610.

https://doi.org/10.1182/blood.V130.Suppl_1.5610.5610

Published: 2017

Journal Articles

Arsenic Trioxide and Interferon-Alpha Eradicate Adult T Cell Leukemia Initiating Cells through PML/p53 Senescence and Activation of Innate Immunity

Hiba El Hajj, Dr, Rita Hleihel, Zaatari Ghazi, Julie Bruneau, Hideki Hasegawa, William Hall, Olivier Hermine, MD PhD, Hugues de The, MD PhD, Ali Bazarbachi, MD PhD

Blood (2017) 130 (Supplement 1): 1233.

https://doi.org/10.1182/blood.V130.Suppl_1.1233.1233

Published: 2017

Journal Articles

Epidemiology, Clinical Features, and Outcome of HTLV-1 Related Adult T-Cell Leukemia-Lymphoma in a Prevalent Area in the United States

Luis E Malpica Castillo, MD, Agustin Pimentel, MD, Isildinha M Reis, PhD, Eduardo Gotuzzo, MD, Lazaros J. Lekakis, MD, Krishna Komanduri, MD, Thomas J. Harrington, MD, Glen N. Barber, PhD, Juan Carlos Ramos, MD BS

Blood (2017) 130 (Supplement 1): 373.

https://doi.org/10.1182/blood.V130.Suppl_1.373.373

Published: 2017

Journal Articles

Targeting CD30 Expression in Adult T-Cell Leukemia-Lymphoma (ATLL)

Luis E Malpica Castillo, MD, German Campuzano-Zuluaga, MD, Ngoc L Toomey, BS, Agustin Pimentel, MD, Alvaro J. Alencar, MD, Jennifer Rose Chapman-Fredricks, MD, Juan Carlos Ramos, MD BS

Blood (2017) 130 (Supplement 1): 374.

https://doi.org/10.1182/blood.V130.Suppl_1.374.374

Published: 2017

Journal Articles

Impact of IRF4/MUM1 Expression on Adult T-Cell Leukemia/Lymphoma and Treatment Outcome

Luis E Malpica Castillo, MD, German Campuzano-Zuluaga, MD, Ngoc L Toomey, BS, Agustin Pimentel, MD, Jennifer Rose Chapman-Fredricks, MD, Juan Carlos Ramos, MD BS

Blood (2017) 130 (Supplement 1): 4134.

https://doi.org/10.1182/blood.V130.Suppl_1.4134.4134

Published: 2017

Journal Articles

CDK9 inhibition for ATL therapy

Ali Bazarbachi

Blood (2017) 130 (9): 1074–1075.

https://doi.org/10.1182/blood-2017-07-793372

Published: 2017

Journal Articles

Targeting Ikkα in CLL: Inhibition of Non-Canonical NF-κb Signaling Decreases Survival and Proliferation of CD40L-Stimulated Primary CLL Cells

Elaine Willmore, PhD, Aaron Gardner, PhD, Susan J Tudhope, PhD, Andrew Herridge, BSc, Jill Hunter, Jonathan P Wallis, MD, Helen J Marr, MD PhD, Giacomo Berretta, PhD, David Breen, PhD, Andrew Paul, PhD, Darren Edwards, PhD, Louise C Young, PhD, Colin J Suckling, PhD, Robin Plevin, PhD, Marie Boyd, PhD, James M Allan, DPhil, Simon Mackay, PhD, Neil D Perkins, PhD

Blood (2016) 128 (22): 3959.

https://doi.org/10.1182/blood.V128.22.3959.3959

Published: 2016

Journal Articles

ATL treatment: is it time to change?

Olivier Hermine

Blood (2015) 126 (24): 2533–2534.

https://doi.org/10.1182/blood-2015-10-670489

Published: 2015

Journal Articles

Adult T-Cell Leukemia/Lymphoma: A Clinical and Epidemiological Analysis at the Medicine School of Sao Paulo University

Ana Costa Cordeiro, MD, Luis Alberto de Padua Covas Lage, MD, Renata Oliveira Costa, Debora Levy, Juliana Pereira, MD PhD

Blood (2015) 126 (23): 5091.

https://doi.org/10.1182/blood.V126.23.5091.5091

Published: 2015

Journal Articles

Azatidine Treatment in Very Elderly Patients Diagnosed with Acute Myelogenous Leukemia (AML) or High Risk Myelodysplastic Syndrome (MDS)

Javier Gutierrez, MD, Elena Morales, MD, Matilde Gonzalez, MD, Juan Herrada, MD

Blood (2015) 126 (23): 5262.

https://doi.org/10.1182/blood.V126.23.5262.5262

Published: 2015

Journal Articles

The Combination of Belinostat with Zidovudine for Treatment of HTLV-I Related Adult T-Cell Leukemia-Lymphoma

Ngoc Toomey, Juan Carlos Ramos, MD

Blood (2015) 126 (23): 1562.

https://doi.org/10.1182/blood.V126.23.1562.1562

Published: 2015

Journal Articles

Initial Experience with Thrombopoetin Receptor Agonists (TRA) in 5 Patients with Refractory HIV-Associated Immune Thrombocytopenic Purpura (ITP)

Mark Kowalczyk, Paul G. Rubinstein, MD, David M Aboulafia, MD

Blood (2014) 124 (21): 5014.

https://doi.org/10.1182/blood.V124.21.5014.5014

Published: 2014

Journal Articles

Achievement of Complete Hematological Remission and Reversal of High HTLV-1 Viral Loads with Anti CCR-4 Monoclonal Antibody Administration in Afro Caribbean Patients with Relapsed Chronic Adult T Cell Leukaemia (ATLL)

Paul Fields, MD PhD, Maria Demontis, PhD, Lucy Cook, MD PhD, Sasha Marks, MDFRCPath,FRCP, David Wrench, MD PhD, Arief Gunawan, MBChB, MRCP, Claire Woodley, RN, Graham Taylor, MD FRCP

Blood (2014) 124 (21): 5474.

https://doi.org/10.1182/blood.V124.21.5474.5474

Published: 2014

Journal Articles

Using HDAC Inhibitors to Eradicate Adult T-Cell Leukemia-Lymphoma

Agustin Pimentel, MD, Isildinha Reis, DrPH, Ngoc Toomey, Luis Diaz, Phillip Ruiz, MD PhD, Graham Taylor, MD FRCP, Juan Carlos Ramos, MD

Blood (2014) 124 (21): 5492.

https://doi.org/10.1182/blood.V124.21.5492.5492

Published: 2014

Journal Articles

Epstein-Barr Virus Kinase-Targeted Therapy for Primary Central Nervous System Post-Transplant Lymphoproliferative Disorder

James Dugan, MD MS, Bradley M. Haverkos, MD MPH, Ludmila Katherine Martin, MD, Marisa F. Martin, Mark E Lustberg, MD PhD, John T. Patton, PhD, Gerard Nuovo, MD, Fengting Yan, MD, PhD, Robert Cavaliere, MD, Shannon C. Kenney, MD, Joyce Fingeroth, MD, Gerard Lozanski, MD, Juan Carlos Ramos, MD, Pierluigi Porcu, MD, Michael A. Caligiuri, MD, Robert A. Baiocchi, MD PhD

Blood (2014) 124 (21): 1750.

https://doi.org/10.1182/blood.V124.21.1750.1750

Published: 2014

Journal Articles

The Combination Of Arsenic, Interferon-Alpha, and Zidovudine Restores An “Immunocompetent-like” Micro-Environment In Patients With Adult T-Cell Leukemia/Lymphoma

Ghada Kchour, S. A. Rahim Rezaee, Reza Farid, Akram Ghantous, Houshang Rafatpana, Mahdi Tarhini, Mohamad-Mehdi Kooshyar, Hiba El Hajj, PhD, Fadwa Berry, Roudaina Nasser, Abbas Shirdel, Zeina Dassouki, Mohamad Ezzedine, Hossein Rahimi, Ardeshir Ghavamzadeh, Hugues de Thé, MD, PhD, Olivier Hermine, MD, PhD, Mahmoud Mahmoudi, Ali Bazarbachi, MD, PhD

Blood (2013) 122 (21): 5100.

https://doi.org/10.1182/blood.V122.21.5100.5100

Published: 2013

Journal Articles

Outcome Of Patients With HTLV-1 Associated Adult T-Cell Leukemia/Lymphoma (ATL) Who Have Undergone Stem Cell Transplantation: A Retrospective Study Of The EBMT Lymphoma Working Party

Ali Bazarbachi, MD, PhD, Kate Cwynarski, Ariane Boumendil, PhD, Herve Finel, Paul Fields, MD, PhD, Kavita Raj, MD, PhD, MRCP, FRCPath, Arnon Nagler, MD, MSc, Mohamad Mohty, MD, PhD, Anna Sureda, MD, Peter Dreger, MD, Olivier Hermine, MD, PhD

Blood (2013) 122 (21): 3398.

https://doi.org/10.1182/blood.V122.21.3398.3398

Published: 2013

Journal Articles

Clinical Features, Treatment Outcome, and Predictive Biomarkers In Adult T-Cell Leukemia/Lymphoma: University Of Miami Experience

Agustin Pimentel, MD, German Campuzano-Zuluaga, MD, Luis Diaz, Jennifer R. Chapman-Fredricks, MD, Juan Carlos Ramos, MD

Blood (2013) 122 (21): 1340.

https://doi.org/10.1182/blood.V122.21.1340.1340

Published: 2013

NARROW

Pilot Study of Tocilizumab in Patients with HIV and Symptomatic Kaposi Sarcoma Herpesvirus (KSHV)-Associated Multicentric Castleman Disease

Clinicogenetic risk modeling in ATL

Adult T-Cell Leukemia/Lymphoma: Clinical Characteristics and Outcome of Aggressive Subtypes Treated at a Tertiary Cancer Center

Arsenic Trioxide and Interferon-Alpha Eradicate Adult T Cell Leukemia Initiating Cells through PML/p53 Senescence and Activation of Innate Immunity

Epidemiology, Clinical Features, and Outcome of HTLV-1 Related Adult T-Cell Leukemia-Lymphoma in a Prevalent Area in the United States

Targeting CD30 Expression in Adult T-Cell Leukemia-Lymphoma (ATLL)

Impact of IRF4/MUM1 Expression on Adult T-Cell Leukemia/Lymphoma and Treatment Outcome

CDK9 inhibition for ATL therapy

Targeting Ikkα in CLL: Inhibition of Non-Canonical NF-κb Signaling Decreases Survival and Proliferation of CD40L-Stimulated Primary CLL Cells

ATL treatment: is it time to change?

Adult T-Cell Leukemia/Lymphoma: A Clinical and Epidemiological Analysis at the Medicine School of Sao Paulo University

Azatidine Treatment in Very Elderly Patients Diagnosed with Acute Myelogenous Leukemia (AML) or High Risk Myelodysplastic Syndrome (MDS)

The Combination of Belinostat with Zidovudine for Treatment of HTLV-I Related Adult T-Cell Leukemia-Lymphoma

Initial Experience with Thrombopoetin Receptor Agonists (TRA) in 5 Patients with Refractory HIV-Associated Immune Thrombocytopenic Purpura (ITP)

Achievement of Complete Hematological Remission and Reversal of High HTLV-1 Viral Loads with Anti CCR-4 Monoclonal Antibody Administration in Afro Caribbean Patients with Relapsed Chronic Adult T Cell Leukaemia (ATLL)

Using HDAC Inhibitors to Eradicate Adult T-Cell Leukemia-Lymphoma

Epstein-Barr Virus Kinase-Targeted Therapy for Primary Central Nervous System Post-Transplant Lymphoproliferative Disorder

The Combination Of Arsenic, Interferon-Alpha, and Zidovudine Restores An “Immunocompetent-like” Micro-Environment In Patients With Adult T-Cell Leukemia/Lymphoma

Outcome Of Patients With HTLV-1 Associated Adult T-Cell Leukemia/Lymphoma (ATL) Who Have Undergone Stem Cell Transplantation: A Retrospective Study Of The EBMT Lymphoma Working Party

Clinical Features, Treatment Outcome, and Predictive Biomarkers In Adult T-Cell Leukemia/Lymphoma: University Of Miami Experience

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only